266 related articles for article (PubMed ID: 24565782)
1. Unexpected decrease in total IgE in a patient with allergic bronchopulmonary aspergillosis treated with omalizumab.
Wolf BL; Johnson A
J Allergy Clin Immunol Pract; 2014; 2(1):111-3. PubMed ID: 24565782
[No Abstract] [Full Text] [Related]
2. A case of allergic bronchopulmonary aspergillosis treated with omalizumab.
Sastre I; Blanco J; Mata H; García F
J Investig Allergol Clin Immunol; 2012; 22(2):145-7. PubMed ID: 22533243
[No Abstract] [Full Text] [Related]
3. Anti IgE antibody as treatment of allergic bronchopulmonary aspergillosis in a patient with cystic fibrosis.
Zicari AM; Celani C; De Castro G; Valerio De Biase R; Duse M
Eur Rev Med Pharmacol Sci; 2014 Jul; 18(13):1839-41. PubMed ID: 25010610
[TBL] [Abstract][Full Text] [Related]
4. Successful Treatment of Allergic Bronchopulmonary Aspergillosis With Benralizumab in a Patient Who Did Not Respond to Omalizumab.
Bernal-Rubio L; de-la-Hoz Caballer B; Almonacid-Sánchez C; González-de-Olano D
J Investig Allergol Clin Immunol; 2020; 30(5):378-379. PubMed ID: 32376515
[No Abstract] [Full Text] [Related]
5. Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence.
Tanou K; Zintzaras E; Kaditis AG
Pediatr Pulmonol; 2014 May; 49(5):503-7. PubMed ID: 24167019
[TBL] [Abstract][Full Text] [Related]
6. Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis.
Voskamp AL; Gillman A; Symons K; Sandrini A; Rolland JM; O'Hehir RE; Douglass JA
J Allergy Clin Immunol Pract; 2015; 3(2):192-9. PubMed ID: 25640470
[TBL] [Abstract][Full Text] [Related]
7. Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis.
Altman MC; Lenington J; Bronson S; Ayars AG
J Allergy Clin Immunol Pract; 2017; 5(4):1137-1139. PubMed ID: 28279664
[No Abstract] [Full Text] [Related]
8. Successful carboplatin desensitization by using omalizumab and paradoxical diminution of total IgE levels.
Ojaimi S; Harnett PR; Fulcher DA
J Allergy Clin Immunol Pract; 2014; 2(1):105-6. PubMed ID: 24565780
[No Abstract] [Full Text] [Related]
9. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2013 Sep; (9):CD010288. PubMed ID: 24043500
[TBL] [Abstract][Full Text] [Related]
10. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2015 Nov; (11):CD010288. PubMed ID: 26545165
[TBL] [Abstract][Full Text] [Related]
11. Anti-IgE therapy for allergic bronchopulmonary aspergillosis.
Homma T; Kurokawa M; Matsukura S; Yamaguchi M; Adachi M
J Microbiol Immunol Infect; 2016 Jun; 49(3):459-63. PubMed ID: 24291616
[TBL] [Abstract][Full Text] [Related]
12. Measured immunoglobulin E in allergic bronchopulmonary aspergillosis treated with omalizumab.
Lin RY; Sethi S; Bhargave GA
J Asthma; 2010 Oct; 47(8):942-5. PubMed ID: 20831464
[TBL] [Abstract][Full Text] [Related]
13. Omalizumab in the management of steroid dependent allergic bronchopulmonary aspergillosis (ABPA) complicating cystic fibrosis.
Wong R; Wong M; Robinson PD; Fitzgerald DA
Paediatr Respir Rev; 2013 Mar; 14(1):22-4. PubMed ID: 23287795
[TBL] [Abstract][Full Text] [Related]
14. Itraconazole as 'bridge therapy' to anti-IgE in a patient with severe asthma with fungal sensitisation.
Pizzimenti S; Bussolino C; Badiu I; Rolla G
BMJ Case Rep; 2013 Apr; 2013():. PubMed ID: 23598928
[TBL] [Abstract][Full Text] [Related]
15. Anti-IgE therapy for allergic bronchopulmonary aspergillosis in people with cystic fibrosis.
Jat KR; Walia DK; Khairwa A
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD010288. PubMed ID: 29551015
[TBL] [Abstract][Full Text] [Related]
16. Allergic bronchopulmonary aspergillosis and omalizumab.
Tillie-Leblond I; Germaud P; Leroyer C; Tétu L; Girard F; Devouassoux G; Grignet JP; Prudhomme A; Dusser D; Wallaert B
Allergy; 2011 Sep; 66(9):1254-6. PubMed ID: 21517902
[No Abstract] [Full Text] [Related]
17. Omalizumab, an additional therapy for allergic bronchopulmonary aspergillosis.
Evans MO; Morris MJ; Coop CA; Evans SE
Ann Allergy Asthma Immunol; 2015 Sep; 115(3):250-1. PubMed ID: 26162570
[No Abstract] [Full Text] [Related]
18. [The role of allergological tests in allergic bronchopulmonary aspergillosis (ABPA)].
Bumbăcea RS; Ghiordănescu I; Petruţescu B
Pneumologia; 2012; 61(2):102-7. PubMed ID: 22783601
[TBL] [Abstract][Full Text] [Related]
19. [Role of omalizumab in the management of allergic bronchopulmonary aspergillosis in patients with cystic fibrosis].
Delgado Pecellín I; Quintana Gallego E; Pedregal Solano C; Calero Acuña C
Med Clin (Barc); 2015 Feb; 144(4):190-1. PubMed ID: 25015245
[No Abstract] [Full Text] [Related]
20. Case series of allergic bronchopulmonary aspergillosis treated successfully and safely with long-term mepolizumab.
Soeda S; To M; Kono Y; Yamawaki S; Tsuzuki R; Katsube O; Watanabe N; To Y
Allergol Int; 2019 Jul; 68(3):377-379. PubMed ID: 30704844
[No Abstract] [Full Text] [Related]
[Next] [New Search]
